Keyword results: Susan Searle

Fake_News
PREMIUM CONTENT

A major article for the Transparency Task Force Woodford session to discuss today – its from the FT!

As you know I got disinvited from speaking at the TTF symposium taking place today which aims to discover what went wrong with Neil Woodford and how to stop it happening again. As the one journalist who did expose Woodford from 2015 onwards, one point I wanted to make was that the corruption of the deadwood press as an enabler of fraud was an issue but that was going to make the chap from the FT a bit cross.  So here below, is an article from the FT in December 2017 for the establishment arse lickers at the TTF to consider. You will see it is branded as among “FT’s personal finance highlights of 2017.”

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

Schroder UK Public Private Trust (formerly WPCT) – Annual Report: Monster write-downs but still a Bargepole

Schroder UK Public Private Trust (SUPP) – formerly Neil Woodford’s Patient Capital Trust (WPCT) has released its Annual Report for FY20 and the shocking write-downs are all too apparent, although no surprise to ShareProphets as we warned of this all along. The good news is that the gearing has been paid off and the company now finds itself with over 3% cash now that investee Kymab has been sold. But the red ink is everywhere, and led to another severe drop in NAV as write-down after write-down took their toll.

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

Schroder UK Public Private Trust – formerly WPCT – Shocking Revaluation as Reality Begins to Bite at Rutherford

Schroder UK Public Private Trust (SUPP) – formerly Neil Woodford’s Patient Capital Trust (WPCT) – slipped out a new but unaudited net asset value statement yesterday at 3.32pm and it was shocking: it wiped another 20% off the previously stated NAV to bring the official figure down to just 35.01p per share. That, against the fantasy 89.07p when the flagship Woodford fund, Woodford Equity Income, was gated on 3 June 2019.

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

….And the good news is: Woodford biotech dogs sold

Of course, the bad news is that the worst of them haven’t been sold and the buyer, Acacia Research, got a thumping discount. The news of the discount should come as no surprise to ShareProphets readers, as Tom Winnifrith, Cynical Bear and I have all warned of as much. And with the absolute dogs left over, there is surely more pain to come for Neil Woodford's motley crew of hard-up former investors into hs Equity Income Fund.

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

SUPPing at the cup of failure - former WPCT releases results

Schroder UK Public Private Trust (SUPP) - formerly disgraced Neil Woodford’s Patient Capital Trust (WPCT) - has released its FY19 numbers and the report is truly a dog’s breakfast. It is a shambles: the manager has gone but the board should be sacked at once.

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

WPCT to become Schroder UK Public Private Trust as Susan Searle plays the patriotic card and Neil leaves the building

Shareholders in Woodford Patient Capital Trust (WPCT) were this morning invited to celebrate as Susan Searle announced the appointment of Schroders to replace the disgraced Neil Woodford as manager.  There will thus be no need for Neil to work out his notice period following his "trresignation" last week.

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

Susan Searle and WPCT: more on that appointment of Raymond Abbott - a safe pair of hands or Butterfingers?

Last week one of the highlights for me was the shadow of incompetence spreading at Neil's Woodford Patient Capital Trust (WPCT) as it tried to reassure the market with the appointment of Raymond Abbott to its board. What Susan Searle, the Chair of WPCT, would have hoped is that the appointment of Mr Abbott would be seen as a safe pair of hands. Naturally she will have done her homework, which is why the original RNS of Monday had to be corrected, after my prompt,  as it mis-named one of Mr Abbot’s previous appointments and missed another off altogether. But is Mr Abbott a safe pair of hands or butterfingers?

Subscribe to ShareProphets to access Premium Content

WPCT offers a glass of Ouzo to the Deputy Sheriff with…er….consequences

Well that only took four days – well done Woodford Patient Capital (WPCT) and its Chair, Susan Searle. On Monday it announced the appointment of Mr Raymond Abbott as a new director – but got one of his former companies wrong, missed out another and has still neglected to mention that Foresight 4 VCT suffered a £30 million accounting error on his watch as chairman of the audit committee,,an error under FCA investigation, and a further £3 million accounting error after he was rewarded for his outstanding service and promoted to Chairman of the company.

WPCT board change – and another thing on the appointment of that fine Mr Abbott

Having mentioned two major blunders already, it seems that new appointment Raymond Abbott to the board of WPCT (whose previous directorships are yet to be corrected by WPCT) has another major blunder on his hands – and it is back at Foresight 4 VCT where, having presided over a £30 million blunder as chairman of the audit committee (and he a trained accountant) he was promoted to Chairman. Let us now turn to the FY18 accounts of Foresight 4……

PREMIUM CONTENT

Woodford Patient Capital releases Interims – and ‘fesses up that its stated NAV was a fiction

Susan Searle, Chair of Woodford Patient Capital Trust (WPCT), really does have some explaining to do as WPCT released its half-year numbers to the market this morning – reporting deadline day. Quite apart from the shocking performance of the fund under her watch, and the total mess it is in, we have been treated to an admission that the quoted NAVs released by the company have, quite simply, been wrong - a work of fiction.

Subscribe to ShareProphets to access Premium Content
Bearcast
PREMIUM CONTENT

Tom Winnifrith Bearcast: Firing Neil Woodford is not enough for WPCT

Woodford Patient Capital Trust (WPCT) has results tomorrow. There is talk that Britan's most conceited fund manager may be fired but if Susan Searle and her fellow directors think that gets them or the company off the hook, she is badly mistaken. PS. There is a joke for NoGold 30 seconds in.

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

Woodford Patient Capital Trust – the most pathetic of statements, shares slide again

I see that the spin doctors for Woodford Patient Capital Trust (WPCT) told their poodles in the deadwood press (the FT) to run a fake news article suggesting that vultures were circling looking to bid for the company and its assets. No-one, not even the PR cocksuckers at the Financial Times, believes that for a minute and the shares have slumped again today to 59p, despite, or perhaps in part because of, the weediest of statements from WPCT.

Subscribe to ShareProphets to access Premium Content
Collapsing-Reactor

CORRECTION: Neil Woodford – a better day today! (All things are relative, not fired by anyone till late afternoon)

Well, the Income Focus Fund hasn’t been suspended yet and nobody’s sacked him today. Ooops TW Correction, it has just em erged that the mandate to manage the £330 million Omnis Fund has been terminated by Openwork. Woodford is utterly toxic. So, as Nigel was saying, until late this afternoon no-one had sacked Neil Woodford so that counts as a good day....

PREMIUM CONTENT

An Open Letter to Susan Searle at WPCT No 2 – Neil Woodford must be fired now to save our company

Susan Searle, the fragrant chairwoman of Woodford Patient Capital Trust (WPCT), where I am a loyal owner of 10 shares, has yet to respond to my polite letter demanding she suspend the shares, fire Neil Woodford and undertake a strategic review. But events now force me to write again in light of Woodford’s incoherent video of earlier.  That suggests WPCT now faces a full blown crisis. The letter follows:

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

Letter to WPCT Chair Susan Searle – suspend the shares, fire Neil Woodford for misleading us at AGM & strategic review asap

As you may recall I invested £8 to become a loyal shareholder in the Woodford Patient Capital Trust (WPCT) and attended its AGM on May 16 to give Neil Woodford a right duffing up. Woodford misled that meeting and for that, as well as gross incompetence, he should be fired at once. I have written to our great leader, chair Susan Searle with calls for immediate action. The letter is below:

Subscribe to ShareProphets to access Premium Content
Atomic

What now as Woodford Equity Income Fund suspends trading? Shimples: carnage - China Syndrome time

Well shock, horror, probe! As predicted on ShareProphets for months, Neil Woodford’s Equity Income Fund has had to suspend dealing in its units with immediate effect, until further notice, to allow time to reposition the element of the fund’s portfolio invested in unquoted and less liquid stocks, in to more liquid investments. You can’t say you were not warned here on ShareProphets – and whilst it may be Ouzo time here for Tom Winnifrith and me, spare a thought for Cynical Bear who unpicked so much (and now has to get his dancing shoes out!) So what now?

Bearcast
PREMIUM CONTENT

Tom Winnifrith Bearcast: Susan Searle of WPCT J'accuse & Great Scott: Revolution Bars is enough to turn a man to drink

I suggest listening to my Neil Woodford scandal bonus bearcast first HERE but I have another bone to pick with Susan Searle, the chairman of Woodford Patient Capital Trust (WPCT) on how she has screwed investirs today. Then I look nat Red Emperor (RMP), 88 Energy (88E), Pantheon Resources (PANR) and at Cabot Energy (CAB). Finally a look at the latest woes at Revolution Bars (RBG) - you really would have thought that Britain's thirstiest share blogger would have nailed this as his specialist subject but it appears not. If you enjoyed this podcast please support the EIGHT rogue bloggers for Woodlarks with a small donation HERE

Subscribe to ShareProphets to access Premium Content

WPCT Interims: Some good news but a few questions

Following my piece this morning on Woodford (HERE), I note that Woodford Patient Capital Trust (WPCT) published its interims at the rather odd time of 9.45am today which ruins my competition to some extent. Anyway, there is some good news in there that I am happy to report but it still begs a few questions that I am also happy to ask in my general nit-picking way.

PREMIUM CONTENT

Oh dear, why is everyone leaving Woodford’s Immunocore? Has the “unicorn hunter” struck again?

I’ve touched on Immunocore a few times in passing as it one of the largest holdings in Woodford Patient Capital Trust (WPCT) as well as being the largest investment made by Dublin-listed Malin Corporation, of which Woodford is the largest shareholder, obvs! Well, it looks like it’s not a particularly happy ship and I wonder whether a (further) devaluation is required?

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

Woodford and the $2 billion spoof – Part 2: How many reasons do you want?

The first part of this mini-series highlighted oddities relating to the recent $2 billion valuation of Benevolent AI, Woodford’s largest unquoted holding. To complement that piece, I thought I would undertake a bottom-up analysis to understand whether it could be worth such a sum. All I found was more spoofery. It’s a bit of a long read but surely you’ve got nothing better to do on Bank Holiday Monday!

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

Woodford and the $2 billion spoof – Part 1: More odd-looking funding

In my view, Woodford’s dealings with what is now his largest unquoted holding across his funds, Benevolent AI, is his kryptonite and will be his undoing and I’m doing a couple of articles outlining why I think the current $2 billion valuation is an absolute spoof and why I believe Neil Woodford is complicit in said spoofery.

Subscribe to ShareProphets to access Premium Content

WPCT: A review of the laughable results and three important questions for the Chairman

Woodford Patient Capital Trust (WPCT) recently came out with its disappointing 2017 results and thought I’d highlight a few amusing aspects to try to cheer up shareholders here and ask a few serious questions of the Chairman, Susan Searle.

Woodford Patient Capital: The Big Short (Appendix 1) – The (not so) “independent” Board of Directors

I made reference in my concluding part of “The Big Short” on Woodford Patient Capital Trust (WPCT) about a potential Appendix or two to deal with some of the detail, so here’s the first providing more information on the WPCT Board Directors which, as Tom has pointed out during his Christmas Eve Bearcast, are not particularly independent at all and there is a significant conflict of interest issue.

Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Complete Coverage

Recent Comments

|